Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

NCT00184574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

603

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: metformin

Sponsor

Novo Nordisk A/S